Acumen Pharmaceuticals, Inc.
ABOS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26 | -$41 | -$29 | -$37 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2 | $2 | $0 |
| Change in WC | -$7 | $6 | -$7 | $8 |
| Other Non-Cash | $3 | $0 | -$0 | $2 |
| Operating Cash Flow | -$30 | -$32 | -$34 | -$27 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$3 | -$35 | -$15 |
| Inv. Sales/Matur. | $41 | $42 | $64 | $45 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $41 | $38 | $29 | $30 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$1 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1 |
| Financing Cash Flow | $0 | $0 | -$0 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $10 | $7 | -$5 | $2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37 | $30 | $36 | $33 |
| End Cash | $47 | $37 | $30 | $36 |
| Free Cash Flow | -$30 | -$32 | -$34 | -$27 |